Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials

Total article views   Abstract views HTML views PDF downloads Totals
6,673 Dovepress* 5,824 496+ 1,188 6,320
PubMed Central* 0 353 118 353
Totals 5,824 849 1,306 6,673
*Since 4 May 2018
+Since July 2016

View citations on PubMed Central and Google Scholar